Research and Development

The Research and Development team at Spirovant Sciences focuses on advancing innovative gene therapies aimed at treating cystic fibrosis and other pulmonary diseases. This multidisciplinary group, led by senior leadership, collaborates on preclinical and clinical research initiatives, ensuring the scientific rigor and strategic alignment of projects to optimize the development pipeline and bring groundbreaking treatments to patients.